Biosensor Regulatory Pathway: EU MDR, IVDR & FDA Classification Guide
How to navigate EU MDR, IVDR, and FDA regulatory pathways for biosensor medical devices. Classification, clinical evidence, and strategies for startups.
April 2026For Biotech & Pharma Professionals
Free tools for EU MDR classification, submission tracking, and eCTD organization — plus a blog covering the regulatory landscape for biomedical devices and pharmaceuticals.
MDR device classification, submission tracking, and eCTD document organization — no enterprise license needed.
View all tools →Practical articles on EU MDR, FDA submissions, clinical evaluations, and regulatory strategy for SMEs.
Read articles →Designed by regulatory professionals who understand the challenges small biotech and pharma teams face every day.
Get in touch →Everything a small regulatory team needs — nothing it doesn’t.
Step-by-step device classification following EU MDR Annex VIII rules. Get a clear risk class with supporting rationale.
Track submissions from draft through approval and organize your technical documentation. Full portfolio overview with audit trail.
Practical regulatory insights for biotech and pharma teams.
How to navigate EU MDR, IVDR, and FDA regulatory pathways for biosensor medical devices. Classification, clinical evidence, and strategies for startups.
April 2026Navigate 2026 MDR deadlines with a practical action plan covering EUDAMED, NB capacity, and compliance budgeting.
February 2026Navigate the IVDR transition with practical timelines, NB strategies, and cost estimates for small laboratories.
February 2026